$Icon PLC (ICLR.US)$
Major Breakthrough: ICON Leads Clinical Research Evolution with AI-Powered Medidata Platform

$Quest Diagnostics (DGX.US)$
Quest Diagnostics Revolutionizes Lab Testing With Google Cloud AI Partnership

$Labcorp Holdings (LH.US)$ $Opko Health (OPK.US)$
Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth

$Labcorp Holdings (LH.US)$
Can a Simple Blood Draw Replace Tumor Biopsies? Labcorp's New Cancer Test Changes the Game

$IQVIA Holdings (IQV.US)$   wondering why no movement for this stock despite good target price from institutions ?

$Charles River (CRL.US)$ It’s cheap, but no sizable upside without material improvement of the earnings. 140s might be in the cards. Go against the trend is a dangerous thing. Those sitting on a loss have to cut loss given the extreme resistance above. Only improvement of the earnings can save this stock. They also seem to be losing some clients to competitors.

$IQVIA Holdings (IQV.US)$ Will be over 220 by the end of the month

$Charles River (CRL.US)$ In this almost everything rally market with stocks doubling easily, biomedical research companies have found growth is extremely hard to come by, and P/E has been stuck going nowhere.